Telomerase contributes to tumorigenesis by a telomere length-independent mechanism
Open accessThe DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
Abstract
Once immortalized, human cells are susceptible to transformation by introduction of an oncogene such as ras . Several lines of evidence now suggest that the maintenance of telomere length is a major determinant of replicative lifespan in human cells and thus of the immortalized state. The majority of human tumor cells acquire immortality through expression of the catalytic subunit of telomerase (hTERT), whereas others activate an alternative mechanism of telomere maintenance (ALT) that does not depend on the actions of telomerase. We have examined whether ALT could substitute for telomerase in the processes of transformation in vitro and tumorigenesis in vivo . Expression of oncogenic H-Ras in the immortal ALT cell line GM847 did not result in their transformation. However, subsequent ectopic expression of hTERT in these cells imparted a tumorigenic phenotype. Indeed, this outcome was also observed after introduction of a mutant hTERT that retained catalytic activity but was incapable of maintaining telomere length. These studies indicate that hTERT confers an additional function that is required for tumorigenesis but does not depend on its ability to maintain telomeres.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Overexpression experiments in transgenic mice and in human cells have shown that TERT exhibits activities in cellular transformation (136-138), proliferation (139), stem cell biology (140-142), cell survival (143,144) and chromatin regulation (145).”
From Telomeres and telomerase in cancer (2010) · cites this paper as [136]
The cited source says what the claim attributes to it.
In the citing paper
“Moreover, recent findings indicate that TERT promotes tumor development even in settings of ample telomere reserve, although the mechanisms underlying these telomere length-independent activities of TERT remain unclear9–13.”
From Conditional telomerase induction causes proliferation of hair follicle stem cells (2005) · cites this paper as [11]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
RETRACTED: Autoimmunity as a Consequence of Retrovirus-Mediated Expression of C-FLIP in Lymphocytes
Parijs, L. V., Refaeli, Y., Abbas, A. K., & Baltimore, D. (1999) · Immunity · doi:10.1016/s1074-7613(00)80150-8 · Cited by 149
RetractedAutoimmunity as a Consequence of Retrovirus-Mediated Expression of C-FLIP in Lymphocytes
Parijs, L. V., Refaeli, Y., Abbas, A. K., & Baltimore, D. (2009) · Immunity · doi:10.1016/j.immuni.2009.04.003 · Cited by 31
RetractedThe serial cultivation of human diploid cell strains
Hayflick, L., & Moorhead, P. S. (1961) · Experimental Cell Research · doi:10.1016/0014-4827(61)90192-6 · Cited by 8,508
Specific Association of Human Telomerase Activity with Immortal Cells and Cancer
Kim, N. W., Piatyszek, M. A., Prowse, K. R., Harley, C. B., West, M. D., Ho, P. L. C., Coviello, G. M., Wright, W. E., Weinrich, S. L., & Shay, J. W. (1994) · Science · doi:10.1126/science.7605428 · Cited by 7,091
Telomeres shorten during ageing of human fibroblasts
Harley, C. B., Futcher, A. B., & Greider, C. W. (1990) · Nature · doi:10.1038/345458a0 · Cited by 5,750
Extension of Life-Span by Introduction of Telomerase into Normal Human Cells
Bodnar, A. G., Ouellette, M., Frolkis, M., Holt, S. E., Chiu, C.-P., Morin, G. B., Harley, C. B., Shay, J. W., Lichtsteiner, S., & Wright, W. E. (1998) · Science · doi:10.1126/science.279.5349.349 · Cited by 4,975
Mammalian Telomeres End in a Large Duplex Loop
Griffith, J. D., Comeau, L., Rosenfield, S., Stansel, R. M., Bianchi, A., Moss, H., & de Lange, T. (1999) · Cell · doi:10.1016/s0092-8674(00)80760-6 · Cited by 2,447
Creation of human tumour cells with defined genetic elements
Hahn, W. C., Counter, C. M., Lundberg, A. S., Beijersbergen, R. L., Brooks, M. W., & Weinberg, R. A. (1999) · Nature · doi:10.1038/22780 · Cited by 2,345
Self-citationTelomerase Catalytic Subunit Homologs from Fission Yeast and Human
Nakamura, T. M., Morin, G. B., Chapman, K. B., Weinrich, S. L., Andrews, W. H., Lingner, J., Harley, C. B., & Cech, T. R. (1997) · Science · doi:10.1126/science.277.5328.955 · Cited by 2,256
Counter, C. M., Avilion, A. A., LeFeuvre, C. E., Stewart, N. G., Greider, C. W., Harley, C. B., & Bacchetti, S. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05245.x · Cited by 2,096
Research works printed but not linked: 4
- Rich J N, Guo C, McLendon R E, Bigner D D, Wang X F, Counter C M. Cancer Res. 2001;61:3556–3560. [PubMed] [Google Scholar]
- Kuperwasser C, Pinkas J, Hurlbut G D, Naber S P, Jerry D J. Cancer Res. 2000;60:2723–2729. [PubMed] [Google Scholar]
- Zimonjic D, Brooks M W, Popescu N, Weinberg R A, Hahn W C. Cancer Res. 2001;61:8838–8844. [PubMed] [Google Scholar]
- Yeager T R, Neumann A A, Englezou A, Huschtscha L I, Noble J R, Reddel R R. Cancer Res. 1999;59:4175–4179. [PubMed] [Google Scholar]
Cited by
Items 101–200 of 434
Telomere‐based DNA damage responses: a new approach to melanoma
Puri, N., Eller, M. S., Byers, H. R., Dykstra, S. G., Kubera, J., & Gilchrest, B. A. (2004) · The FASEB Journal · doi:10.1096/fj.04-1774com · Cited by 80
“Expression of telomerase confers immortality on cells, but recent work demonstrates that telomerase affects immortalized cells in ways other than maintenance of telomere length that promote their transformation ( 21 ).”
BackgroundDome, J. S., Bockhold, C. A., Li, S. M., Baker, S., Green, D. M., Perlman, E. J., Hill, D. A., & Breslow, N. E. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.00.562 · Cited by 82
Cayuela, M. L., Flores, J. M., & Blasco, M. A. (2005) · EMBO reports · doi:10.1038/sj.embor.7400359 · Cited by 76
“The telomerase RNA component Terc is required for the tumour-promoting effects of Tert overexpression”
BackgroundModels of breast cancer: quo vadis, animal modeling?
Wagner, K. (2003) · Breast Cancer Research · doi:10.1186/bcr723 · Cited by 81
“This conclusion is supported by the fact that a mutant of TERT lacking the capability of extending telomeres still retains its tumorigenic properties in cells that use alternative mechanisms of telomere maintenance [21].”
Backgroundde Magalhães, J. P., Debacq‐Chainiaux, F., de Longueville, F., Mainfroid, V., Migeot, V., Marcq, L., Remacle, J., Salmon, M., & Toussaint, O. (2004) · Experimental Gerontology · doi:10.1016/j.exger.2004.06.004 · Cited by 80
“The observed downregulation of SOD2 in hTERT-BJ1 HDFs confirms reports that telomerase may favor tumorigenesis by a telomere lengthindependent mechanism (Stewart et al., 2002; Lindvall et al., 2003).”
BackgroundMasutomi, K., & Hahn, W. C. (2003) · Cancer Letters · doi:10.1016/s0304-3835(02)00703-6 · Cited by 83
Self-citationIdentification of PITX1 as a TERT Suppressor Gene Located on Human Chromosome 5
Qi, D.-L., Ohira, T., Fujisaki, C., Inoue, T., Ohta, T., Osaki, M., Ohshiro, E., Seko, T., Aoki, S., Oshimura, M., et al. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.00470-10 · Cited by 84
“meres, resulting in continuous cell division (1, 15, 16, 48).”
BackgroundDyrk2-associated EDD-DDB1-VprBP E3 Ligase Inhibits Telomerase by TERT Degradation
Jung, H., Wang, X., Jun, S., & Park, J. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.416792 · Cited by 80
Villa, R., Daidone, M. G., Motta, R., Venturini, L., Marco, C. D., Vannelli, A., Kusamura, S., Baratti, D., Deraco, M., Costa, A., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0099 · Cited by 79
Ogawa, D., Nomiyama, T., Nakamachi, T., Heywood, E. B., Stone, J. F., Berger, J. P., Law, R. E., & Bruemmer, D. (2006) · Circulation Research · doi:10.1161/01.res.0000218271.93076.c3 · Cited by 72
The many faces of telomerase: emerging extratelomeric effects
Bollmann, F. M. (2008) · BioEssays · doi:10.1002/bies.20793 · Cited by 74
“An ALTcell line that was not able to form tumors invivo acquired that ability upon transfection of TERT.((15)) However, in a later study when Universitätsklinikum Hamburg-Eppendorf, Martinistrasse 52, 20246”
BackgroundSaha, D., Singh, A., Hussain, T., Srivastava, V., Sengupta, S., Kar, A., Dhapola, P., Dhople, V., Ummanni, R., & Chowdhury, S. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.792077 · Cited by 72
“In contrast, in about 85% of all cancers, hTERT expression is reactivated (11), leading to malignant transformation and aggressive metastasis in many cases (12).”
BackgroundTelomere-driven genomic instability in cancer cells
Desmaze, C., Soria, J., Freulet-Marrière, M.-A., Mathieu, N., & Sabatier, L. (2003) · Cancer Letters · doi:10.1016/s0304-3835(02)00704-8 · Cited by 80
Multiple Mechanisms of Telomere Maintenance Exist in Liposarcomas
Johnson, J. E., Varkonyi, R. J., Schwalm, J., Cragle, R., Klein–Szanto, A. J., Patchefsky, A. S., Cukierman, E., von Mehren, M., & Broccoli, D. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0684 · Cited by 81
Telomerase expression in the mammalian heart
Richardson, G. D., Breault, D., Horrocks, G., Cormack, S., Hole, N., & Owens, W. A. (2012) · The FASEB Journal · doi:10.1096/fj.12-208843 · Cited by 70
“differentiation (4), including transcriptional regulation”
Stadler, G., Chen, J. C. J., Wagner, K. R., Robin, J. D., Shay, J. W., Emerson, C. P., & Wright, W. E. (2011) · Skeletal Muscle · doi:10.1186/2044-5040-1-12 · Cited by 75
“phenotype [15,21,22]. However, this latter notion has been challenged by the observation of putative non-telomeric activities of hTERT [ 23-25 ], with strong evidence for its potential to modulate the Wnt pathway in mice [26].”
BackgroundCurrent Insights to Regulation and Role of Telomerase in Human Diseases
Ozturk, M., Li, Y., & Tergaonkar, V. (2017) · Antioxidants · doi:10.3390/antiox6010017 · Cited by 67
“However, when TERT was co-expressed with H-Ras, these cells became tumorigenic and this transformation was independent of the catalytic activity of TERT, suggesting that hTERT has additional roles in cancer promotion that are distinct from its activity at telomeres [75].”
BackgroundhTERT promotes cell adhesion and migration independent of telomerase activity
Liu, H., Liu, Q., Ge, Y., Zhao, Q., Zheng, X., & Zhao, Y. B. (2016) · Scientific Reports · doi:10.1038/srep22886 · Cited by 76
Telomeres and chromosomal instability
Mathieu, N., Pirzio, L. M., Freulet-Marrière, M.-A., Desmaze, C., & Sabatier, L. (2004) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-003-3296-0 · Cited by 77
Do Sunscreens Increase or Decrease Melanoma Risk: An Epidemiologic Evaluation
Weinstock, M. A. (1999) · Journal of Investigative Dermatology Symposium Proceedings · doi:10.1038/sj.jidsp · Cited by 73
Wei, W., Jobling, W. A., Chen, W., Hahn, W. C., & Sedivy, J. M. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.8.2859-2870.2003 · Cited by 68
“Whether activation of telomerase is required only for extension of life span or also has a component in the anchorage-independent phenotype itself (69, 81) is not addressed by our experiments, because the p21 / DK cell line was close to the end of its replicative life span at the time of Ras transformation.”
BackgroundSelf-citationTransforming growth factor-β inhibits telomerase through SMAD3 and E2F transcription factors
Lacerte, A., Korah, J., Roy, M., Yang, X., Lemay, S., & Lebrun, J. J. (2007) · Cellular Signalling · doi:10.1016/j.cellsig.2007.08.012 · Cited by 75
Telomeres, telomerase, and tumorigenesis--a review.
Lin, K. W. (2004) · PubMed · Cited by 89
Beck, S. J., Jin, X., Sohn, Y.-W., Kim, J.-K., Kim, S.-H., Yin, J., Pian, X., Kim, S.-C., Nam, D., Choi, Y.-J., et al. (2010) · Molecules and Cells · doi:10.1007/s10059-011-0008-8 · Cited by 70
Functional genetics and experimental models of human cancer
Zhao, J. J., Roberts, T. M., & Hahn, W. C. (2004) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2004.05.005 · Cited by 71
Self-citationMolecular chaperones in mammary cancer growth and breast tumor therapy
Calderwood, S. K., & Gong, J. (2011) · Journal of Cellular Biochemistry · doi:10.1002/jcb.23461 · Cited by 66
“Senescence can be avoided by the expression in breast cancer cells of the enzyme telomerase that can rebuild the telomere and maintain prolific levels of proliferation [Stewart et al., 2002; Jaskelioff et al., 2009].”
BackgroundLiu, C., Liu, Z., Chen, T., Zeng, W., Guo, Y., & Huang, T. (2016) · Scientific Reports · doi:10.1038/srep36990 · Cited by 68
Telomerase reverse transcriptase in the regulation of gene expression
Zhou, J., Ding, D., Wang, M., & Cong, Y. (2014) · BMB Reports · doi:10.5483/bmbrep.2014.47.1.284 · Cited by 63
Miyazu, Y., Miyazawa, T., Hiyama, K., Kurimoto, N., Iwamoto, Y., Matsuura, H., Kanoh, K., Kohno, N., Nishiyama, M., & Hiyama, E. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0976 · Cited by 62
“Recently, it was proved in vitro that once telomerase is activated, human cells are susceptible to transformation (19), and human bronchial epithelial cells can be immortalized by activation of Figure 1.”
BackgroundTelomerase extracurricular activities
Chang, S., & DePinho, R. A. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.212514699 · Cited by 60
On the origin of telomeres: a glimpse at the pre-telomerase world
Nosek, J., Kosa, P. F., & Tomáška, Ľ. (2006) · BioEssays · doi:10.1002/bies.20355 · Cited by 65
Generation of Telomeric G Strand Overhangs Involves Both G and C Strand Cleavage
Jacob, N. K., Kirk, K. E., & Price, C. M. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00131-x · Cited by 59
Imamura, S., Uchiyama, J., Koshimizu, E., Hanai, J.-I., Raftopoulou, C., Murphey, R. D., Bayliss, P. E., Imai, Y., Burns, C. E., Masutomi, K., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003364 · Cited by 58
“Although it is now clear that telomerase expression is crucial for the maintenance of telomere homeostasis, there is increasing evidence that the TERT protein can have physiological roles that are independent of this central function [5,25,29,35,36,37,38,39,40].”
BackgroundMolecular regulation of telomerase activity in aging
Nicholls, C., Li, H., Wang, J.-Q., & Liu, J.-P. (2011) · Protein & Cell · doi:10.1007/s13238-011-1093-3 · Cited by 53
“Similarly, C-terminally tagged hTERT is unable to lengthen telomeres yet can facilitate anchorage-independent growth and tumor formation in xenograft mice (Stewart et al., 2002).”
Tang, B., Xie, R., Qin, Y., Xiao, Y., Yong, X., Zheng, L., Dong, H. F., & Yang, S. (2015) · Oncotarget · doi:10.18632/oncotarget.6575 · Cited by 63
“In addition, there is an increasing evidence implicating hTERT in cancer, not only by maintaining telomeres but also via mechanisms independent of telomere lengthening [8, 9].”
BackgroundHe, B., Xiao, Y., Tang, B., Wu, Y., Hu, C.-J., Xie, R., Yang, X., Yu, S., Dong, H. F., Zhao, X., et al. (2016) · Scientific Reports · doi:10.1038/srep21955 · Cited by 61
Bu, R., Siraj, A. K., Divya, S. P., Kong, Y., Parvathareddy, S. K., Al-Rasheed, M. M., Al‐Obaisi, K. A. S., Victoria, I. G., Al-Sobhi, S. S., Aldawish, M., et al. (2017) · International Journal of Cancer · doi:10.1002/ijc.31225 · Cited by 61
The Solo Play of TERT Promoter Mutations
Hafezi, F., & Perez-Bercoff, D. (2020) · Cells · doi:10.3390/cells9030749 · Cited by 60
Recent advances in telomere biology: implications for human cancer
Meeker, A. K., & De Marzo, A. M. (2004) · Current Opinion in Oncology · doi:10.1097/00001622-200401000-00007 · Cited by 56
Estimation of Human Age According to Telomere Shortening in Peripheral Blood Leukocytes of Tibetan
Ren, F., Li, C., Xi, H., Wen, Y., & Huang, K. (2009) · American Journal of Forensic Medicine & Pathology · doi:10.1097/paf.0b013e318187df8e · Cited by 58
“It is well known that telomerase, consists of 2 main components, telomere RNA which acts as a template for telomere synthesis, and telomere reverse transcription which catalyzes the elongation, seems to serve as a factor of stabilization telomere length.(24) Kyo et al reported that telomere reverse transcription is bo…”
BackgroundTelomerase Inhibition Using Azidothymidine in the HT-29 Colon Cancer Cell Line
Brown, T. A., Sigurdson, E. R., Rogatko, A., & Broccoli, D. (2003) · Annals of Surgical Oncology · doi:10.1245/aso.2003.03.032 · Cited by 60
The human telomere and its relationship to human disease, therapy, and tissue engineering
Moon, I. (2007) · Frontiers in Bioscience · doi:10.2741/2412 · Cited by 54
“Subsequently, it was demonstrated that a mutant of hTERT, a C-terminal HA-tagged hTERT version that was catalytically active but unable to maintain telomeres in cells, conferred a tumorigenic phenotype (149).”
BackgroundTelomerase Inhibition in Cancer Therapeutics: Molecular-Based Approaches
Publisher, B. S. (2006) · Current Medicinal Chemistry · doi:10.2174/092986706778521887 · Cited by 60
Chapman, E., Kelly, G. P., & Knowles, M. A. (2008) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-07-2168 · Cited by 60
“Non–telomere effects of hTERT expression have been described in other cell types, some of which may be relevant to tumorigenesis in vivo (3, 4).”
BackgroundCancer-specific loss of TERT activation sensitizes glioblastoma to DNA damage
Amen, A. M., Fellmann, C., Soczek, K. M., Ren, S. M., Lew, R. J., Knott, G. J., Park, J. E., McKinney, A., Mancini, A., Doudna, J. A., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2008772118 · Cited by 55
Melatonin and non-small cell lung cancer: new insights into signaling pathways
Pourhanifeh, M. H., Sharifi, M., Reiter, R. J., Davoodabadi, A., & Asemi, Z. (2019) · Cancer Cell International · doi:10.1186/s12935-019-0853-7 · Cited by 54
“HTERT is a critical component of human telomerase which lengthens the ends of linear chromosome as well as maintaining their stability; this results in cellular immortalization [70].”
Creating oral squamous cancer cells: A cellular model of oral–esophageal carcinogenesis
Goessel, G., Quante, M., Hahn, W. C., Harada, H., Heeg, S., Suliman, Y., Doebele, M., von Werder, A., Fulda, C., Nakagawa, H., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409730102 · Cited by 65
Self-citationHuang, F., Chang, C., Lou, P., Kuo, I.-C., Chien, C., Chen, C., Shieh, F.-Y., Chang, T., & Lin, J. (2008) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-07-0260 · Cited by 53
“Alternatively, it was shown that telomerase could have a role on tumor progression in a telomere-independent manner (45, 46).”
BackgroundTelomerase can act as a template- and RNA-independent terminal transferase
Lue, N. F., Bosoy, D., Moriarty, T. J., Autexier, C., Altman, B., & Leng, S. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0502252102 · Cited by 49
Sensitivity of Yeast Strains with Long G-Tails to Levels of Telomere-Bound Telomerase
Vega, L. R., Phillips, J. A., Thornton, B. R., Benanti, J. A., Onigbanjo, M. T., Toczyski, D. P., & Zakian, V. A. (2007) · PLoS Genetics · doi:10.1371/journal.pgen.0030105 · Cited by 52
High efficiency creation of human monoclonal antibody-producing hybridomas.
Dessain, S., Adekar, S. P., Stevens, J. B., Carpenter, K. A., Skorski, M., Barnoski, B., Goldsby, R., & Weinberg, R. (2004) · JIM - Journal of Immunological Methods · doi:10.1016/j.jim.2004.05.005 · Cited by 51
Self-citationDetection of telomerase activity in saliva from oral squamous cell carcinoma patients
Zhong, L., Chen, G.-F., Xu, Z., Zhang, X., Ping, F., & Zhao, S. (2005) · International Journal of Oral and Maxillofacial Surgery · doi:10.1016/j.ijom.2004.10.007 · Cited by 50
Heeg, S., Hirt, N., Queisser, A., Schmieg, H., Thaler, M., Kunert, H., Quante, M., Goessel, G., von Werder, A., Harder, J., et al. (2011) · Cancer Science · doi:10.1111/j.1349-7006.2010.01796.x · Cited by 46
HIV-1 Vpr Protein Inhibits Telomerase Activity via the EDD-DDB1-VPRBP E3 Ligase Complex
Wang, X., Singh, S., Jung, H.-Y., Yang, G., Jun, S., Sastry, K. J., & Park, J.-I. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.416735 · Cited by 47
Madonna, R., Willerson, J. T., & Geng, Y. (2007) · Stem Cells · doi:10.1634/stemcells.2007-0490 · Cited by 52
Gollin, S. M. (2003) · Current Opinion in Oncology · doi:10.1097/00001622-200401000-00006 · Cited by 58
Telomerase stimulates ribosomal DNA transcription under hyperproliferative conditions
Gonzalez, O. G., Assfalg, R., Koch, S., Schelling, A., Meena, J. K., Kraus, J. M., Lechel, A., Katz, S., Beneš, V., Scharffetter‐Kochanek, K., et al. (2014) · Nature Communications · doi:10.1038/ncomms5599 · Cited by 50
Huang, H., Huang, K.-F., Li, C.-L., Huang, Y.-Y., Chiang, Y.-H., Huang, F.-C., & Lin, J. (2008) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2008.05.072 · Cited by 48
Queisser, A., Heeg, S., Thaler, M., von Werder, A., & Opitz, O. G. (2013) · Cancer Genetics · doi:10.1016/j.cancergen.2013.10.001 · Cited by 50
Tsang, A. R., Wyatt, H. D. M., Ting, N. S. Y., & Beattie, T. L. (2012) · Aging Cell · doi:10.1111/j.1474-9726.2012.00810.x · Cited by 46
“In these noncanonical roles, telomerase may function in the promotion of tumourigenesis (Stewart et al., 2002) and cell survival (Lee et al.”
BackgroundTárkányi, I., & Aradi, J. (2007) · Biochimie · doi:10.1016/j.biochi.2007.09.002 · Cited by 52
Non-telomeric activities of telomerase
Majerská, J., Sýkorová, E., & Fajkus, J. (2011) · Molecular BioSystems · doi:10.1039/c0mb00268b · Cited by 48
Papathomas, T. G., Oudijk, L., Zwarthoff, E. C., Post, E., Duijkers, F. A. M., van Noesel, M. M., Hofland, L. J., Pollard, P. J., Maher, E. R., Restuccia, D. F., et al. (2014) · Endocrine Related Cancer · doi:10.1530/erc-13-0429 · Cited by 49
“…non-canonical functions interfering with extra-telomeric tumor-promoting pathways remains to be elucidated (Greider & Blackburn 1985, Cao et al. 2002, Stewart et al. 2002, Choi et al. 2008, Parkinson et al. 2008, Park et al. 2009, Martinez & Blasco 2011, Mukherjee et al. 2011, Liu et al. 2013b).”
BackgroundEllingsen, E. B., Mangsbo, S. M., Hovig, E. J., & Gaudernack, G. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.682492 · Cited by 48
“These findings are in line with the described tumorigenic contribution of hTERT besides telomere elongation (119).”
Ellingsen, E. B., Aamdal, E., Guren, T. K., Lilleby, W. A., Brunsvig, P. F., Mangsbo, S. M., Aamdal, S., Hovig, E. J., Mensali, N., Gaudernack, G., et al. (2022) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2021-004345 · Cited by 49
FEN1 contributes to telomere stability in ALT-positive tumor cells
Saharia, A., & Stewart, S. A. (2009) · Oncogene · doi:10.1038/onc.2008.458 · Cited by 57
Self-citationTeichroeb, J. H., Kim, J., & Betts, D. H. (2016) · RNA Biology · doi:10.1080/15476286.2015.1134413 · Cited by 52
Telomere biology in giant cell tumour of bone
Forsyth, R. G., Boeck, G. D., Bekaert, S., Meyer, T. D., Taminiau, A. T., Uyttendaele, D., Roels, H., PRAET, M., & Hogendoorn, P. C. W. (2008) · The Journal of Pathology · doi:10.1002/path.2301 · Cited by 46
“Telomerase is endowed with additional functions independent of telomere elongation activity measured by the TRAP assay [27,33].”
MethodTelomerase reverse transcriptase regulates the expression of a key cell cycle regulator, cyclin D1
Jagadeesh, S., & Banerjee, P. P. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.06.172 · Cited by 55
Senthilkumar, P. K., Klingelhutz, A. J., Jacobus, J. A., Lehmler, H., Robertson, L. W., & Ludewig, G. (2011) · Toxicology Letters · doi:10.1016/j.toxlet.2011.04.012 · Cited by 45
High incidence of TERT mutation in brain tumor cell lines
Johanns, T. M., Fu, Y., Kobayashi, D. K., Mei, Y., Dunn, I. F., Mao, D. D., Kim, A. H., & Dunn, G. P. (2016) · Brain Tumor Pathology · doi:10.1007/s10014-016-0257-5 · Cited by 46
“mental evidence that additional extratelomeric functions of this enzyme may be operative in the cancer setting [21].”
BackgroundImmortalized Muscle Cell Model to Test the Exon Skipping Efficacy for Duchenne Muscular Dystrophy
Nguyen, Q., & Yokota, T. (2017) · Journal of Personalized Medicine · doi:10.3390/jpm7040013 · Cited by 46
Antitumor Activity of Systemically Delivered Ribozymes Targeting Murine Telomerase RNA
Nosrati, M., Li, S., Bagheri, S., Ginzinger, D. G., Blackburn, E. H., Debs, R. J., & Kashani–Sabet, M. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0134 · Cited by 45
“The importance of telomerase in cancer is supported by studies showing that telomerase expression promotes production of tumorigenic cell lines (6, 7) and by its very frequent activation in human cancers (8–10).”
BackgroundGoldman, A. J., Chen, H. D. R., Roesly, H. B., Hill, K. A., Tome, M. E., Dvořák, B., Bernstein, H., & Dvorak, K. (2010) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00461.2010 · Cited by 51
CDK2 translational down-regulation during endothelial senescence
Freedman, D. A., & Folkman, J. (2005) · Experimental Cell Research · doi:10.1016/j.yexcr.2005.03.025 · Cited by 47
TGF-β and cancer: Is Smad3 a repressor of hTERT gene?
Li, H., Xu, D., Toh, B., & Liu, J. (2006) · Cell Research · doi:10.1038/sj.cr.7310023 · Cited by 50
Subramanian, L., Moser, B. A., & Nakamura, T. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.01614-07 · Cited by 44
“Although previous studies have suggested that TERT could have telomere protection roles independent of its extension function (36, 54, 69), these putative “protective” functions of TERT generally still required TERT to be catalytically active.”
BackgroundPan, Y., Meng, M., Zheng, N., Cao, Z., Yang, P., Xi, X., & Zhou, Q. (2016) · Biochemical Pharmacology · doi:10.1016/j.bcp.2016.11.024 · Cited by 42
“resulting in cell immortalization and malignant progression [22-32].”
BackgroundInfluentialTelomerase as a Growth-Promoting Factor
Gorbunova, V. A., & Seluanov, A. (2003) · Cell Cycle · doi:10.4161/cc.2.6.515 · Cited by 45
Involvement of Telomerase Reverse Transcriptase in Heterochromatin Maintenance
Maida, Y., Yasukawa, M., Okamoto, N., Ohka, S., Kinoshita, K., Totoki, Y., Ito, T. K., Minamino, T., Nakamura, H. K., Yamaguchi, S., et al. (2014) · Molecular and Cellular Biology · doi:10.1128/mcb.00093-14 · Cited by 42
Tárkányi, I., Dudognon, C., Hillion, J., Pendino, F., Lanotte, M., Aradi, J., & Ségal-Bendirdjian, E. (2005) · Leukemia · doi:10.1038/sj.leu.2403923 · Cited by 42
Alternative lengthening of telomeres: dangerous road less travelled
Reddel, R. R., & Bryan, T. M. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13538-6 · Cited by 42
Uziel, O., Beery, E., Dronichev, V., Samocha, K., Gryaznov, S. M., Weiss, L., Slavin, S., Kushnir, M., Nordenberg, Y., Rabinowitz, C., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009132 · Cited by 44
“[33–35].”
hTERT promotes the invasion of telomerase-negative tumor cells in vitro
Yang, Y. (2009) · International Journal of Oncology · doi:10.3892/ijo_00000344 · Cited by 45
“Stewart and colleagues (17) found that the transfection of TERT enabled an ALT cell line to form a subcutaneous tumor, which could not be achieved before transfection.”
BackgroundTERT, a promoter of CNS malignancies
Patel, B., Taiwo, R., Kim, A. H., & Dunn, G. P. (2020) · Neuro-Oncology Advances · doi:10.1093/noajnl/vdaa025 · Cited by 44
Alcaraz‐Pérez, F., García‐Castillo, J., García‐Moreno, D., López‐Muñoz, A., Anchelin, M., Angosto-Bazarra, D., Zon, L. I., Mulero, V., & Cayuela, M. L. (2014) · Nature Communications · doi:10.1038/ncomms4228 · Cited by 42
Zhang, Z., Yu, L., Dai, G., Xia, K., Liu, G., Song, Q., Tao, C., Gao, T., & Guo, W. (2017) · Scientific Reports · doi:10.1038/s41598-017-07204-w · Cited by 41
Yamada, O., Ozaki, K., Furukawa, T., Machida, M., Wang, Y., Motoji, T., Mitsuishi, T., Akiyama, M., Yamada, H., Kawauchi, K., et al. (2011) · Cellular Signalling · doi:10.1016/j.cellsig.2011.02.005 · Cited by 41
Gourronc, F. A., Robertson, M. M., Herrig, A. K., Lansdorp, P. M., Goldman, F. D., & Klingelhutz, A. J. (2010) · Experimental Dermatology · doi:10.1111/j.1600-0625.2009.00916.x · Cited by 48
Alberti, L., Losi, L., Leyvraz, S., & Benhattar, J. (2015) · PLoS ONE · doi:10.1371/journal.pone.0132977 · Cited by 40
“Indeed, it has been demonstrated that hTERT/telomerase has also telomere-independent functions [37] and an overexpression of hTERT led cells more resistant to several insults, such as treatment with chemotherapeutic [31–32].”
BackgroundTelomerase activates transcription of cyclin D1 gene through an interaction with NOL1
Hong, J., Lee, J. H., & Chung, I. K. (2016) · Journal of Cell Science · doi:10.1242/jcs.181040 · Cited by 42
ZEB1 stimulates breast cancer growth by up-regulating hTERT expression
Pan, Y., Shen, X. H., Yang, W., Zhang, Y., Liu, C., & Huang, T. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.12.139 · Cited by 41
Telomeres and Telomerase in Stem Cells during Aging and Disease
Ju, Z., & Rudolph, K. L. (2006) · KARGER eBooks · doi:10.1159/000092502 · Cited by 44
Chebel, A., Rouault, J.-P., Urbanowicz, I., Baseggio, L., Chien, W. W., Salles, G. A., & Ffrench, M. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.009183 · Cited by 45
Senescence; an endogenous anticancer mechanism
Vargas, J. E., Feltes, B. C., Poloni, J. D. F., Lenz, G., & Bonatto, D. (2012) · Frontiers in bioscience · doi:10.2741/4074 · Cited by 43
“The ALT mechanism is found in a minority of tumors, where it compensates for the lack of TERT, increasing the length of telomeres and allowing indefinite cell proliferation (104).”
BackgroundTerrin, L., Dolcetti, R., Corradini, I., Indraccolo, S., Col, J. D., Bertorelle, R., Bonaldi, L., Esposito, G., & Rossi, A. D. (2007) · International Journal of Cancer · doi:10.1002/ijc.22661 · Cited by 42
“Furthermore, recent data suggests that, besides its ability to maintain telomere length, hTERT may also mediate several other cellular functions, including the promotion of cell growth,(17,18) inhibition of apoptosis and enhanced tumorigenesis.(22)”
Backgroundp53-dependent integration of telomere and growth factor deprivation signals
Beliveau, A., Bassett, E., Lo, A. T., Garbe, J., Rubio, M. A., Bissell, M. J., Campisi, J., & Yaswen, P. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0700260104 · Cited by 38
Menzel, O., Migliaccio, M., Goldstein, D. R., Dahoun, S., Delorenzi, M., & Rufer, N. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.6.3657 · Cited by 37
“Intriguingly, our results and those of others (29, 31, 32, 36) do not exactly recapitulate those found for hTERT-transduced epithelial cells in which telomerase could induce expression of growthcontrolling genes such as epithelial growth factor receptor (35) or epiregulin (34) and enhance cell proliferation (35, 47).”
ResultCerezo, A., Stark, H., Moshir, S., & Boukamp, P. (2003) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2003.12304.x · Cited by 41
Metadata
- Authors
- Stewart, S. A., Hahn, W. C., O'Connor, B. F., Banner, E. N., Lundberg, A. S., Modha, P., Mizuno, H., Brooks, M. W., Fleming, M., Zimonjic, D. B., Popescu, N. C., & Weinberg, R. A.
- Affiliations
- Brigham and Women's Hospital (US)
- Whitehead Institute for Biomedical Research, Cambridge, MA 02142; Department of Adult Oncology, Dana–Farber Cancer Institute, Boston, MA 02115; Department of Medicine, Brigham and Women's Hospital, Boston, MA 02115; Departments of Medicine and Pathology, Harvard Medical School, Boston, MA 02115; Genzyme, Inc., One Kendall Square, Cambridge, MA 02139; Laboratory of Experimental Carcinogenesis, National Cancer Institute, Bethesda, MD 20892; and Department of Biology, Massachusetts Institute of...
- Corresponding author
- Weinberg, Robert A.
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2002-08-22
- Volume
- 99
- Issue
- 20
- Pages
- 12606-12611
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC130507
- OpenAlex
- W2154837214
- Cited by
- 431
- References
- 53
- Citations by year
- 2026: 1 · 2025: 4 · 2024: 6 · 2023: 7 · 2022: 6 · 2021: 9 · 2020: 9 · 2019: 11 · 2018: 5 · 2017: 14 · 2016: 21 · 2015: 18 · 2014: 22 · 2013: 15 · 2012: 18
- FWCI
- 23.02
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- U.S. Department of Defense
- American Association for Cancer Research
- W. M. Keck Foundation
- Ludwig Institute for Cancer Research
- National Institutes of Health
- National Cancer Institute (KO1CA94223, R01 CA78461, K01CA094223, R01CA078461)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Keywords
- telomerase, hTERT, alternative lengthening of telomeres, carcinogenesis, cell transformation, cell immortalization, replicative lifespan
- MeSH terms
- Catalysis, Cell Division, Cell Transformation, Neoplastic, DNA-Binding Proteins, Electrophoresis, Polyacrylamide Gel, Glucose, Humans, Karyotyping, Kinetics, Luminescent Proteins, Microscopy, Fluorescence, Oxygen, Retroviridae, Time Factors, Tumor Cells, Cultured, Blotting, Western, Telomere, Telomerase, Green Fluorescent Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.